Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Processa Pharmaceuticals Inc., 3 years.
Processa Pharmaceuticals Inc.
Director
Endovia Health Sciences Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Processa Pharmaceuticals Inc. July 30, 2026100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 2026 | Processa Pharmaceuticals Inc. | Option exercise | +203 | — | — |
| Jan 27, 2025 | Processa Pharmaceuticals Inc. | Open-market purchase | +12,400 | $0.80 | $9,920 |
| Jan 30, 2024 | Processa Pharmaceuticals Inc. | Open-market purchase | +8,000 | $2.69 | $21,520 |
| Nov 21, 2023 | Processa Pharmaceuticals Inc. | Other | −55,267 | — | — |
| Oct 12, 2023 | Processa Pharmaceuticals Inc. | Grant or award | +6,000 | $0.30 | $1,800 |
| Oct 10, 2023 | Processa Pharmaceuticals Inc. | Grant or award | +12,000 | $0.21 | $2,520 |
| Jun 27, 2023 | Processa Pharmaceuticals Inc. | Option exercise | +23,636 | — | — |
| Dec 31, 2022 | Processa Pharmaceuticals Inc. | Grant or award | +18,208 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.